Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.

<h4>Background</h4>Smoking is a chronic and relapsing disease, with up to 60% of quitters relapsing within the first year. Transcranial Direct Current Stimulation (tDCS), targets cortical circuits and acutely reduces craving and withdrawal symptoms among cigarette smokers. However, the e...

Full description

Saved in:
Bibliographic Details
Main Authors: Laurie Zawertailo, Helena Zhang, Noreen Rahmani, Tarek K Rajji, Peter Selby
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277408&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540041971236864
author Laurie Zawertailo
Helena Zhang
Noreen Rahmani
Tarek K Rajji
Peter Selby
author_facet Laurie Zawertailo
Helena Zhang
Noreen Rahmani
Tarek K Rajji
Peter Selby
author_sort Laurie Zawertailo
collection DOAJ
description <h4>Background</h4>Smoking is a chronic and relapsing disease, with up to 60% of quitters relapsing within the first year. Transcranial Direct Current Stimulation (tDCS), targets cortical circuits and acutely reduces craving and withdrawal symptoms among cigarette smokers. However, the efficacy of tDCS as an adjunct to standard smoking cessation treatments has not been studied. This study aims to investigate the effectiveness of tDCS in combination with varenicline for smoking cessation. We hypothesize that active tDCS combined with varenicline will improve cessation outcomes compared to sham tDCS combined with varenicline.<h4>Methods</h4>This is a double-blind, sham-controlled randomized clinical trial where fifty healthy smokers will be recruited in Toronto, Canada. Participants will be randomized 1:1 to either active tDCS (20 minutes at 2 mA) or sham tDCS (30 seconds at 2 mA, 19 minutes at 0 mA) for 10 daily sessions (2 weeks) plus 5 follow up sessions, occurring every two weeks for 10 weeks. All participants will be given standard varenicline treatment concurrently for the 12-week treatment period. The primary outcome is 30 day continuous abstinence at end of treatment, confirmed with urinary cotinine. Measurements made at each study visit include expired carbon monoxide, self-reported craving and withdrawal. Three magnetic resonance imaging (MRI) scans will be conducted: two at baseline and one at end of treatment, to assess any functional or structural changes following treatment.<h4>Discussion</h4>For every two smokers who quit, one life is saved from a tobacco-related mortality. Therefore, it is important to develop new and more effective treatment approaches that can improve and maintain long-term abstinence, in order to decrease the prevalence of tobacco-related deaths and disease. Furthermore, the addition of longitudinal neuroimaging can shed light on neural circuitry changes that might occur as a result of brain stimulation, furthering our understanding of tDCS in addiction treatment.<h4>Trial registration</h4>This trial has been registered with Clinicaltrials.gov: NCT03841292 since February 15th 2019 (https://clinicaltrials.gov/ct2/show/NCT03841292)-retrospectively registered.
format Article
id doaj-art-591b7e231f7e437aaea9e0e39f22cbd2
institution Kabale University
issn 1932-6203
language English
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-591b7e231f7e437aaea9e0e39f22cbd22025-02-05T05:32:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011712e027740810.1371/journal.pone.0277408Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.Laurie ZawertailoHelena ZhangNoreen RahmaniTarek K RajjiPeter Selby<h4>Background</h4>Smoking is a chronic and relapsing disease, with up to 60% of quitters relapsing within the first year. Transcranial Direct Current Stimulation (tDCS), targets cortical circuits and acutely reduces craving and withdrawal symptoms among cigarette smokers. However, the efficacy of tDCS as an adjunct to standard smoking cessation treatments has not been studied. This study aims to investigate the effectiveness of tDCS in combination with varenicline for smoking cessation. We hypothesize that active tDCS combined with varenicline will improve cessation outcomes compared to sham tDCS combined with varenicline.<h4>Methods</h4>This is a double-blind, sham-controlled randomized clinical trial where fifty healthy smokers will be recruited in Toronto, Canada. Participants will be randomized 1:1 to either active tDCS (20 minutes at 2 mA) or sham tDCS (30 seconds at 2 mA, 19 minutes at 0 mA) for 10 daily sessions (2 weeks) plus 5 follow up sessions, occurring every two weeks for 10 weeks. All participants will be given standard varenicline treatment concurrently for the 12-week treatment period. The primary outcome is 30 day continuous abstinence at end of treatment, confirmed with urinary cotinine. Measurements made at each study visit include expired carbon monoxide, self-reported craving and withdrawal. Three magnetic resonance imaging (MRI) scans will be conducted: two at baseline and one at end of treatment, to assess any functional or structural changes following treatment.<h4>Discussion</h4>For every two smokers who quit, one life is saved from a tobacco-related mortality. Therefore, it is important to develop new and more effective treatment approaches that can improve and maintain long-term abstinence, in order to decrease the prevalence of tobacco-related deaths and disease. Furthermore, the addition of longitudinal neuroimaging can shed light on neural circuitry changes that might occur as a result of brain stimulation, furthering our understanding of tDCS in addiction treatment.<h4>Trial registration</h4>This trial has been registered with Clinicaltrials.gov: NCT03841292 since February 15th 2019 (https://clinicaltrials.gov/ct2/show/NCT03841292)-retrospectively registered.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277408&type=printable
spellingShingle Laurie Zawertailo
Helena Zhang
Noreen Rahmani
Tarek K Rajji
Peter Selby
Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.
PLoS ONE
title Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.
title_full Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.
title_fullStr Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.
title_full_unstemmed Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.
title_short Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial.
title_sort active versus sham transcranial direct current stimulation tdcs as an adjunct to varenicline treatment for smoking cessation study protocol for a double blind single dummy randomized controlled trial
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277408&type=printable
work_keys_str_mv AT lauriezawertailo activeversusshamtranscranialdirectcurrentstimulationtdcsasanadjuncttovareniclinetreatmentforsmokingcessationstudyprotocolforadoubleblindsingledummyrandomizedcontrolledtrial
AT helenazhang activeversusshamtranscranialdirectcurrentstimulationtdcsasanadjuncttovareniclinetreatmentforsmokingcessationstudyprotocolforadoubleblindsingledummyrandomizedcontrolledtrial
AT noreenrahmani activeversusshamtranscranialdirectcurrentstimulationtdcsasanadjuncttovareniclinetreatmentforsmokingcessationstudyprotocolforadoubleblindsingledummyrandomizedcontrolledtrial
AT tarekkrajji activeversusshamtranscranialdirectcurrentstimulationtdcsasanadjuncttovareniclinetreatmentforsmokingcessationstudyprotocolforadoubleblindsingledummyrandomizedcontrolledtrial
AT peterselby activeversusshamtranscranialdirectcurrentstimulationtdcsasanadjuncttovareniclinetreatmentforsmokingcessationstudyprotocolforadoubleblindsingledummyrandomizedcontrolledtrial